EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Percutaneous Cryoneurolysis of Splanchnic Nerves for Pain Palliation in Patients with Pancreatic Cancer: A Single-Center Experience

David-Dimitris Chlorogiannis, Ioannis Kotsantis, Panagiota Economopoulou, Anastasios Kyriazoglou, Stavros Spiliopoulos, Nikolaos Kelekis, Dimitris K Filippiadis

CardioVascular and Interventional Radiology · 05.08.2025 · 48 (10) · 1438-1446

DOI: 10.1007/s00270-025-04142-3 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 05.08.2025. Verfasst von David-Dimitris Chlorogiannis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, 75 Francis Str, Boston, MA, 02115, USA…. Hauptthemen laut MEDLINE: Splanchnic Nerves, Pancreatic Neoplasms, Palliative Care, Cryosurgery. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To report safety and efficacy (on terms of long-term pain reduction results) after percutaneous splanchnic nerve cryoneurolysis for the treatment of refractory pancreatic cancer-related pain. MATERIALS AND METHODS: This single-center, institutional review board-approved, retrospective observational study recruited consecutive patients with pancreatic cancer-related pain refractory to conservative treatment who underwent CT-guided cryoneurolysis of the splanchnic nerves. Outcomes included overall pain reduction rate (> 4 pain score units in the VAS pain scores), technical success (successful cryoprobe placement at the level of interest), and opioid usage reduction. RESULTS: Fifty patients were included (mean age 65 ± 7 years). Overall, clinically relevant pain reduction was achieved in 76% of the patients (38/50). Baseline mean self-reported pain score was 9.52 ± 0.6 (range 8-10) reduced to a mean value of 4.36 ± 2.9, 4.23 ± 3, and 4.43 ± 3.1 after 1, 6, and 12 months, respectively. Technical success was achieved in 100% (50/50) of the patients. Reduction in opioid analgesia usage was observed in 76% (38/50) of the patients. Median overall survival after treatment was 21 months (interquartile range: 6, 36). A statistically significant difference was observed in the self-reported pain scores at 1, 6, and 12 months in patients with and without infiltration of the celiac plexus. No grade > 1b complications, according to the modified CIRSE classification system, were reported. CONCLUSION: This retrospective study highlights that percutaneous cryoneurolysis of the splanchnic nerves is effective and offers long-lasting pain palliation in patients with refractory pancreatic cancer-related pain. This effect is more pronounced when the celiac plexus is not infiltrated by the tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Splanchnic NervesPancreatic NeoplasmsPalliative CareCryosurgeryCancer PainPain ManagementHumansFemaleMaleAgedRetrospective StudiesPain MeasurementTreatment OutcomeMiddle AgedTomography, X-Ray ComputedRadiography, Interventional

Stichwörter der Autor:innen

Computed tomographyCryoanalgesiaCryoneurolysisPainPancreatic cancerSplanchnic nerves

Autor:innen und Institutionen

  • Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, 75 Francis Str, Boston, MA, 02115, USA. dchlorogiannis@bwh.harvard.edu.
  • 2nd Department of Radiology, Medical School, University General Hospital "ATTIKON", National and Kapodistrian University of Athens, 1 Rimini Str, 12462, Haidari/Athens, Greece. dchlorogiannis@bwh.harvard.edu.
  • Department of Medical Oncology, 2nd Department of Internal Medicine, Medical School, University General Hospital "ATTIKON", National and Kapodistrian University of Athens, 1 Rimini Str, 12462, Haidari/Athens, Greece.
  • 2nd Department of Radiology, Medical School, University General Hospital "ATTIKON", National and Kapodistrian University of Athens, 1 Rimini Str, 12462, Haidari/Athens, Greece.

Zitieren

APA

Chlorogiannis, D. D., Kotsantis, I., Economopoulou, P., Kyriazoglou, A., Spiliopoulos, S., Kelekis, N., & Filippiadis, D. K. (2025). Percutaneous Cryoneurolysis of Splanchnic Nerves for Pain Palliation in Patients with Pancreatic Cancer: A Single-Center Experience. CardioVascular and Interventional Radiology, 48(10), 1438-1446. https://doi.org/10.1007/s00270-025-04142-3

Vancouver

Chlorogiannis DD, Kotsantis I, Economopoulou P, Kyriazoglou A, Spiliopoulos S, Kelekis N, et al. Percutaneous Cryoneurolysis of Splanchnic Nerves for Pain Palliation in Patients with Pancreatic Cancer: A Single-Center Experience. CardioVascular and Interventional Radiology. 2025;48(10):1438-1446. doi:10.1007/s00270-025-04142-3

BibTeX
@article{Chlorogiannis2025,
  author = {Chlorogiannis, David-Dimitris and Kotsantis, Ioannis and Economopoulou, Panagiota and Kyriazoglou, Anastasios and Spiliopoulos, Stavros and Kelekis, Nikolaos and Filippiadis, Dimitris K},
  title = {Percutaneous Cryoneurolysis of Splanchnic Nerves for Pain Palliation in Patients with Pancreatic Cancer: A Single-Center Experience},
  journal = {CardioVascular and Interventional Radiology},
  year = {2025},
  volume = {48},
  number = {10},
  pages = {1438--1446},
  doi = {10.1007/s00270-025-04142-3}
}
Kostenlos starten →